Andrei Sevciuc

Head Latam & General Manager Brazil @ Ipsen

About

Key leadership skills and results: Lead successfully within complex matrix organizations to deliver transformation. o Led Portugal to deliver first and boldest business model transformation in Novartis Oncology. o Led Novartis Brazil transition to specialty care capabilities with Cosentyx and Xolair CSU launches. Sense of urgency and courage to act in challenging environments. o Initiated Portugal transformation during covid lockdown, gained momentum through continuous experimentation until full blown change mid-2021. o All-in Cosentyx launch in Brazil with many first-in-class projects that shaped private healthcare market and became industry benchmarks. Instill team culture to both inspire and deliver strong performance. o Consistently delivered highest employee survey ratings among peers (both in BR and PT). o Unwanted turnover on my team was below 2% during 7 years in Novartis. o Cosentyx Brazil was most successful immunology launch ever in the country and delivered more patients vs Humira (market leader) when compared to all top 11 global markets. o Achieved highest market share in EU for Kisqali (breast cancer) during business transformation, surpassing Pfizer for new patient’s 1st line. Consistently lead best-in-class launches in Brazil, Latam, Portugal o Immunology, Oncology, Infectious Diseases. o Launches secured fast and broad market access in Brazil, both for private and public markets Demonstrate high learning agility and create space for other leaders to shine. o Had successful tenure as GM in Portugal, despite multiple changes at same time (1st GM role, move to Europe, new to Oncology). o Nurtured senior leadership team to shine in multiple areas where I had little knowledge/experience.

Country

Brazil

City

São Paulo

Industry

Pharmaceuticals

Skill

Fortalecimento de relacionamento com o cliente, Objetivos de vendas, Resolução de problemas, B2B, Criação de relacionamentos, Country Management, Business Development, European Markets, União Europeia, Negociação, Pensamento crítico, Marketing estratégico, Assuntos corporativos, Vendas, Comunicação, Rollout de novos produtos, Comercial, Digital Marketing, Patient Support, Business Transformation

Experience

Head Latam & General Manager Brazil

Ipsen

2025-2 - Present · 1 yr 8 mos

São Paulo, Brasil

Head Vertical Farma

Stone

2024-7 - 2025-2 · 8 mos

São Paulo, Brazil

Stone Co (Nasdaq: STNE) is a leading provider of financial technology and software solutions that empower merchants and integrated partners to conduct electronic commerce seamlessly across in-store, online, and mobile channels. Stone Co acquired Linx in Jun/21.

Partner - Healthcare & Life Sciences

Amrop Brasil

2023-3 - 2024-6 · 1 yr 4 mos

São Paulo, Brazil

General Manager Portugal

Novartis Oncology

2020-1 - 2023-2 · 3 yrs 2 mos

Lisbon, Portugal

Key projects & accomplishments include: o Led country team to become first in Europe to transform our go-to-market model. o Drove 66% growth in 2021 vs. 2019, delivering superior performance in key growth products. o Achieved highest patient share in Europe and market leadership in 1st-line new patients for mBC. o Executed a successful public affairs engagement to support local National Cancer Plan publication.

Business Unit Director - Immunology & Dermatology

Novartis

2016-1 - 2019-12 · 4 yrs

São Paulo e Região, Brasil

Led and inspired 160+ teammembers. Key projects & accomplishments include: o Spearheaded a cultural transformation, building and supporting an inspired team with improved engagement. • 100% of team felt strongly aligned with company's purpose. • 99% envisioned working for the organization in the long term. • Only 5 involuntary turnovers in 3.5 years, despite competitor growth and attempted poaching. o Directed Cosentyx multiple-indication launch. • Best immuno-biologic launch ever in the Brazilian market. • HMO market share leader, with fastest time to achieve the federal gov reimbursement. o Managed CSU launch and acceleration of Severe Asthma indication. • 2X sales in 3 years.